Antihistamines in the Treatment of Irritable Bowel Syndrome With Diarrhea | MicrobiomeTrials← Back to trialsNCT04612803
Antihistamines in the Treatment of Irritable Bowel Syndrome With Diarrhea
WITHDRAWNPHASE3INTERVENTIONAL
Trial Details
Start: 2020-02-01Est. Completion: 2026-08-31
Enrollment target: 0 participants Locations- UC Health, Cincinnati, Ohio, United States
Other microbiome trials you might be interested in
IBS (Irritable Bowel Syndrome)
Study evaluating the effect of UCB8600 on mast cell activation in the human gut:
IBS is a disease characterized by abdo…
Leuven, BelgiumEst. completion Oct 2027
Disorders of Gut-brain InteractionLifestyle and Dietary InterventionsGastroesophageal Reflux Disease
Gastroesophageal reflux disease (GERD) is a common gastrointestinal disorder, with around 80% of patients experiencing n…
Hualien City, TaiwanEst. completion Dec 31, 2026
Recruiting
Some people living with long-term physical health conditions report feeling dismissed, disbelieved, or not taken serious…
London, United KingdomEst. completion Mar 1, 2027